Company Legal Name
Latest Valuation
Founded Year
Headquarter
SuperDial operates a voice AI platform that automates outbound healthcare phone calls, handling critical administrative tasks including insurance verification, prior authorization, and claims follow-up. Founded in 2021 and headquartered in San Francisco, the company addresses a significant pain point in healthcare operations by replacing manual, time-consuming phone processes with intelligent automation. SuperDial's solution targets healthcare providers, payers, and related organizations seeking to reduce administrative burden and improve operational efficiency. The platform leverages advanced conversational AI to navigate complex healthcare phone systems and complete routine verification tasks. The company continues expanding its AI capabilities while building partnerships within the healthcare ecosystem.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
